Vutrisiran sodium is a small interfering ribonucleic acid (siRNA) agent. It has been indicated for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults.
* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.
